References: Patent Evaluation Central & Peripheral Nervous Systems: Benzimidazole and imidazopyridine derivatives as dopamine D3 receptor antagonists for the treatment of psychosis

Views

CrossRef citations to date

Altmetric

References to Primary Literature

GIROS B el al.: Clonage du gene du recepteur dopamin-ergique 03 humain et identification de son chromo-some. Acad. Sci. Paris (1990) 311:501.
PubMedGoogle Scholar
VAN TOL 1-11-IM et at: Cloning of the gene for a humandopamine 134 receptor with high affinity for the anti-psychotic clozapine. Nature (1991) 350:610.
PubMed Web of Science ®Google Scholar
MEADOR-WOODRUFF JI-1: Neuroanatomy of dopaminereceptor gene expression: potential substrates for neuropsychiatric illness. Clin. Neuropharmacot (1995) 18:514.
Web of Science ®Google Scholar
MURRAY AM et at.: Localization of dopamine 03 recep-tors to mesolimbic and 02 receptors to mesostriatal regions of human forebrain. Proc. Natl. Acad. Sci. USA (1994) 91:11271.
PubMed Web of Science ®Google Scholar
GUREVICH EV et at.: Elevated mesolimbic dopamine 03receptors in schizophrenics are decreased by antipsy-chotics. Arch. Gen. Psychiatry (1996). In press.
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Patent Evaluation Central & Peripheral Nervous Systems: Benzimidazole and imidazopyridine derivatives as dopamine D₃ receptor antagonists for the treatment of psychosis

References to Primary Literature

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Patent Evaluation Central & Peripheral Nervous Systems: Benzimidazole and imidazopyridine derivatives as dopamine D3 receptor antagonists for the treatment of psychosis

References to Primary Literature

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Patent Evaluation Central & Peripheral Nervous Systems: Benzimidazole and imidazopyridine derivatives as dopamine D₃ receptor antagonists for the treatment of psychosis